Guilherme Rocha

Guilherme Rocha

Eli Lilly and Company - Indianapolis / United States
Others
AD Scientific Index ID: 4396220
-
person_outline Guilherme Rocha's MOST POPULAR ARTICLES
1-) Mechanism of baricitinib supports artificial intelligence‐predicted testing in COVID‐19 patients EMBO molecular medicine 12 (8), e12697, 2020
2-) Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulations Arthritis research & therapy 21, 1-10, 2019
3-) Discussion: A tale of three cousins: Lasso, L2Boosting and Dantzig The Annals of Statistics 35 (6), 2373-2384, 2007
4-) Gene expression and pharmacodynamic changes in 1,760 systemic lupus erythematosus patients from two phase III trials of BAFF blockade with tabalumab Arthritis & rheumatology 69 (3), 643-654, 2017
5-) Gene expression and pharmacodynamic changes in 1,760 systemic lupus erythematosus patients from two phase III trials of BAFF blockade with tabalumabRW Hoffman, JT Merrill, MME Alarcón‐Riquelme, M Petri, ER Dow, ...Arthritis & rheumatology 69 (3), 643-654, 2017792017